[Diagnosis and therapeutic correction of changes in the cardiovascular system of patients with prostatic cancer treated with estrogens].
Estrogen-related cardiovascular dysfunction was noted in 23 out of 30 patients with prostatic cancer (PC). Coronary subjects with PC suffered from cardiac pain evident on ECG necessitating correction by effective doses of coronary active drugs. PC patients with essential hypertension exhibited frequent headache, progressive edema of the legs, drastic hypertensive reactions. It is held that estrogen therapy for prostatic cancer should be preceded and monitored by therapeutic evaluation responsible for optimal conditions to prevent and early diagnose cardiovascular complications.
Gembitskiĭ
E V
EV
Portnoĭ
A S
AS
Begunov
A V
AV
D000368:Aged; D000787:Angina Pectoris / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D000959:Antihypertensive Agents / Q000627:therapeutic use; D004028:Dienestrol / Q000627:therapeutic use*; D004562:Electrocardiography; D045166:Estradiol Congeners / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D014665:Vasodilator Agents / Q000627:therapeutic use
D000959:Antihypertensive Agents; D045166:Estradiol Congeners; D014665:Vasodilator Agents; D004028:Dienestrol
Diagnostika i lechebnaia korrektsiia izmeneniĭ serdechno-sosudistoĭ sistemy u bol'nykh rakom predstatel'noĭ zhelezy na fone éstrogeno- terapii.